To address this question, the effect of progestin dose on breast cancer cell invasiveness was tested in the absence or presence of 1nM E2 using recombinant T47D cells that exclusively express PR-A (T47D-A cells) or PR-B (T47D-B cells) (Figure 3A). The gene discussed is S100A6; the disease is breast cancer.